US chemicals company Chemours reported third-quarter 2026 net income of $196 million, up from $46 million a year earlier. Sales increased 3% to $1.54 billion. However, reported profit included $150 million in PFAS-related insurance proceeds. Adjusted net income rose to $31 million, while adjusted EBITDA increased to $200 million, reflecting stronger titanium dioxide pricing and advanced materials demand this quarter.
Chemours Net Profit Jumps to $196 Million
Continue Reading
More coverage on the subjects, companies and places discussed in this article.
Explore this category
Discover more from Bioplastics News
Subscribe to get the latest reporting in your inbox.
